Exploring how iron deficiency anemia affects child development in young children
Study on the Association Between Iron Deficiency Anemia and Neurobehavioral Development and Cognitive Function in Children Aged 6 to 24 Months
Pingshan District Maternal & Child Healthcare Hospital of Shenzhen · NCT06662045
This study looks at how iron deficiency anemia affects the development of young children between 6 to 24 months old, focusing on their motor skills, language, and social behavior.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 6 Months to 6 Years |
| Sex | All |
| Sponsor | Pingshan District Maternal & Child Healthcare Hospital of Shenzhen (other) |
| Locations | 1 site (Shenzhen, China/Guangdong) |
| Trial ID | NCT06662045 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the impact of iron deficiency anemia on neurobehavioral and cognitive development in children aged 6 to 24 months. Conducted in pediatric health clinics in Pingshan District, Shenzhen, China, the study will assess children through blood tests to determine anemia status and evaluate their neurodevelopment using a standardized scale. The research aims to understand how anemia influences motor skills, language ability, social behavior, and overall growth metrics such as weight and height.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 24 months diagnosed with iron deficiency anemia or confirmed non-anemic status.
Not a fit: Patients with congenital or chronic illnesses affecting neurodevelopment, or those with recent severe infections or trauma, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the importance of addressing iron deficiency anemia to improve developmental outcomes in young children.
How similar studies have performed: Other studies have shown a correlation between iron deficiency and developmental delays, suggesting that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 6 to 24 months at the time of enrollment * Diagnosed with iron-deficiency anemia (for the exposure group) or confirmed * non-anemic status (for the control group) based on blood test results * Resident in the study area for at least 6 months prior to enrollment * Availability of parental or guardian consent to participate in the study and willingness to follow study protocols * Completion of all baseline assessments, including neurodevelopmental and physical growth evaluations Exclusion Criteria: * Presence of congenital or chronic illnesses that could affect * neurodevelopment, such as Down syndrome or cerebral palsy. * History of severe infections or trauma within 3 months prior to enrollment that * could influence neurodevelopmental outcomes * Current use of medications or treatments that may interfere with iron metabolism (e.g., iron supplementation or blood transfusions in the last 6 months) * Premature birth (before 37 weeks of gestation) or low birth weight (\< 2,500 grams) * Parental refusal to provide consent or non-compliance with study procedures.
Where this trial is running
Shenzhen, China/Guangdong
- Shenzhen Pingshan District Maternity & Child Healthcare Hospital, Department of Child Healthcare — Shenzhen, China/Guangdong, China (RECRUITING)
Study contacts
- Study coordinator: Moujinsong Project Manager, M.Sc
- Email: 582260375@qq.com
- Phone: +86 075528799171
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Iron-Deficiency Anemia, Neurobehavioral Manifestations, Growth Disorders, Nutritional Status